Unasnemab

Tax included
Unasnemab (MT-3921) is a humanised IgG1 monoclonal antibody that binds to repulsive guidance molecule A (RGMa). Unasnemab improves locomotor function and promotes neuroregeneration and can be used for the research of spinal cord injury.
MedChemExpress 
HY-P99959

Data sheet

Size
Multiple sizes
Reactivity
Others